Glaxo Sees More Competitive Shifts by U.S. Payers

Glaxo Sees More Competitive Shifts by U.S. Payers Play

Feb. 5 (Bloomberg) -- Simon Dingemans, chief financial officer at GlaxoSmithKline Plc, discusses the drugmaker's growth, new products and maintaining competitiveness in the U.S. He speaks with Bloomberg's Makiko Kitamura in London. (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    Bloomberg Bottom Line Watch Now

  • Next

    Street Smart with Trish Regan

blog comments powered by Disqus